Edwards Lifesciences Corp (NYSE: EW): Reassessing Prospects

Edwards Lifesciences Corp (EW) concluded trading on Wednesday at a closing price of $93.02, with 3.19 million shares of worth about $296.68 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 34.46% during that period and on April 3, 2024 the price saw a loss of about -1.37%. Currently the company’s common shares owned by public are about 601.10M shares, out of which, 591.80M shares are available for trading.

However, the stock later moved at a day high price of 92.04, or with a loss of -1.37%. Stock saw a price change of -0.43% in past 5 days and over the past one month there was a price change of 6.89%. Year-to-date (YTD), EW shares are showing a performance of 21.99% which increased to 12.44% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.57 but also hit the highest price of $96.12 during that period. The average intraday trading volume for Edwards Lifesciences Corp shares is 4.07 million. The stock is currently trading 0.28% above its 20-day simple moving average (SMA20), while that difference is up 7.06% for SMA50 and it goes to 18.02% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Edwards Lifesciences Corp (NYSE: EW) currently have 601.10M outstanding shares and institutions hold larger chunk of about 83.26% of that.

The stock has a current market capitalization of $55.93B and its 3Y-monthly beta is at 1.07. PE ratio of stock for trailing 12 months is 40.42, while it has posted earnings per share of $2.30 in the same period. Its PEG reads 4.33 and has Quick Ratio of 2.40 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EW, volatility over the week remained 2.10% while standing at 2.15% over the month.

Stock’s fiscal year EPS is expected to rise by 9.79% while it is estimated to increase by 12.49% in next year. EPS is likely to shrink at an annualized rate of 9.34% for next 5-years, compared to annual growth of 15.35% made by the stock over the past 5-years.

Coverage by Wells Fargo stated Edwards Lifesciences Corp (EW) stock as an Overweight in their note to investors on February 02, 2024, suggesting a price target of $94 for the stock. Stock get an Underperform rating from Wolfe Research on November 28, 2023.

Most Popular

Related Posts